Aflofarm

What Aflofarm does

Aflofarm Farmacja Polska Sp. z o. o. is a privately held Polish pharmaceutical manufacturer headquartered in Pabianice, founded in 1989 and operating across the healthcare sector for approximately 30 years. The company produces and markets prescription (RX) drugs, over-the-counter (OTC) medications, medical devices, cosmetics, and dietary supplements from GMP-certified manufacturing lines, with a portfolio of more than 180 product brands spanning therapeutic areas including antiviral/immune support (Neosine, Neosine Forte, Neosine Duo), smoking cessation (Desmoxan), urinary-tract infection treatment (Dafurag, Dafurag max), NSAIDs and pain management (Opokan, Ibuprofen Aflofarm, Naproxen Aflofarm), cough and cold (Herbapect, FluControl, Envil line), venous insufficiency (Diohespan max, Rostil), and sedatives/sleep aids (Valerin, Melabiorytm), as well as cosmetics (Regenerum, BodyMagnesium).

Aflofarm operates a horizontal, consumer-health business model that generates revenue through one-time sales of pharmaceutical products to general consumers via an extensive pharmacy and retail distribution network in Poland, complemented by export to 31 countries including Hungary, the Czech Republic, Romania, Bulgaria, Turkey, the Netherlands, the United Kingdom, Vietnam, Greece, the United States, former Soviet states (Georgia, Ukraine, Turkmenistan, Azerbaijan), and Middle Eastern markets (Iraq, UAE, Kuwait). Go-to-market combines pharmacy distribution, pharmacist-targeted content (postroniefarmaceuty.pl), consumer-facing digital channels (LinkedIn, Facebook under "postroniezdrowia"), industry event participation (e.g., Cosmoprof Worldwide Bologna), and a press/newsroom function.

The company has held the #1 position in the Polish OTC market since 2012 and employs more than 1,500 staff including pharmacists, physicians, biotechnologists, technologists, and marketers. Aflofarm supplements its commercial operations with an EU co-funded R&D infrastructure programme (9,973,254.00 PLN project, 2,838,430.00 PLN European Funds contribution under the Łódź Voivodeship 2014-2020 programme) and runs a corporate foundation (Fundacja Aflofarm) for health-promotion and CSR activity. Revenue is not publicly disclosed; registered share capital is 26,271,500 PLN, and the company has no disclosed parent, subsidiaries, external investors, or M&A activity in the source material.

Name

Aflofarm

Legal name

Aflofarm Farmacja Polska Sp. z o. o.

Website

https://aflofarm.com.pl

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Aflofarm is a privately held Polish pharmaceutical manufacturer and the #1 company in Poland's OTC market since 2012, producing 180+ prescription, OTC, medical-device, cosmetic, and supplement brands from GMP-certified lines in Pabianice for distribution through domestic pharmacies and exports to 31 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing (OTC, RX, Medical Devices, Cosmetics, Dietary Supplements)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

OTC & Consumer Health Distributors (HLAIAJAC), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medications
• Prescription drugs
• Medical devices
• Dietary supplements

Headquarters

HQ city

Pabianice

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Aflofarm generates revenue through the sale of pharmaceutical products including prescription drugs (RX), over-the-counter medications (OTC), medical devices, cosmetics, and dietary supplements. The company has introduced over 180 product brands to the market, including leading OTC brands such as Desmoxan, Neosine, and Dafurag.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Aflofarm is a Polish pharmaceutical manufacturer that develops, produces, and markets over 180 product brands spanning prescription (RX) and over-the-counter (OTC) medications, medical devices, cosmetics, and dietary supplements. Products are manufactured under GMP standards and distributed through Polish pharmacies and export channels to 31 countries, targeting consumer self-medication, treatment of common ailments, preventive healthcare, and wellness.

Product overview

Aflofarm is Poland's number 1 pharmaceutical company in the OTC (over-the-counter) market, operating for 30 years with a portfolio of 180+ product brands. The company offers a comprehensive range of pharmaceutical and health products organized into five main categories: prescription drugs (RX), OTC medications, medical devices, cosmetics, and dietary supplements. Key product lines include Neosine (antiviral/immunostimulant), Valerin (herbal sedatives), Opokan (NSAIDs), Herbapect (cough treatments), FluControl (cold/flu relief), Dafurag (urinary tract infections), Desmoxan (smoking cessation), and various dermatological/circulatory treatments. The company exports to 31 markets worldwide and employs over 1,500 people including pharmacists, doctors, biotechnologists, and marketers. Products are manufactured according to GMP (Good Manufacturing Practice) standards with rigorous quality control procedures.

Differentiator

Problem solved

Functional benefit

Brands

• Aflofarm Foundation (Fundacja Aflofarm): Corporate social responsibility foundation focused on health promotion and assistance to those in need.

Products and services

• Neosine Antiviral and immunostimulating OTC medicine containing inosine pranobex, used for people with weakened immune systems and recurrent upper respiratory tract infections, also inhibits herpes virus replication. Available as tablets.
• Neosine forte OTC antiviral medicine with 1000mg inosine pranobex per tablet, providing a stronger formulation for immune support and respiratory infection indications.
• Neosine duo Prescription (RX) medication combining inosine pranobex with zinc gluconate for enhanced antiviral and immune support therapy.
• Valerin Herbal sedative OTC medicine containing 200mg valerian root dry extract, indicated for mild nervous tension, anxiety, and sleep difficulties.
• Valerin max Maximum-dose herbal sedative OTC medicine containing 360mg valerian root dry extract per tablet, the highest available single-dose strength in the valerian category.
• Valerin sen Sleep-support dietary supplement combining lemon balm, hops, L-theanine, L-tryptophan, GABA, saffron extract, vitamin B6, and magnesium to support relaxation and healthy sleep.
• Valerin sen z melatoniną Sleep-support dietary supplement containing 1mg melatonin per two tablets combined with hop cones, chamomile, lemon balm extracts, L-theanine, L-tryptophan, GABA, saffron, and vitamin B6.
• Desmoxan OTC smoking cessation treatment containing 1.5mg cytisine per tablet, providing a complete 25-day therapy to reduce nicotine cravings and help quit smoking.
• Dafurag max OTC antibacterial medication for lower urinary tract infections containing maximum 100mg furazidine (furagin) per tablet, the highest single-dose strength in its category.
• Opokan OTC NSAID containing 7.5mg meloxicam per tablet providing 24-hour pain relief for rheumatic diseases, bone and joint pain, and degenerative joint conditions.
• Opokan med Medical device warming patch for external use producing soothing warmth to relax tense muscles, relieve pain, reduce inflammation, and provide relief sensation for up to 12 hours.
• Herbapect Sugar-free OTC cough syrup containing thyme and cowslip extracts with guaiacolsulfonate, indicated for persistent dry cough and difficult expectoration.
• Herbapect junior sugar-free Sugar-free medical device cough syrup for children with marshmallow root and Icelandic moss extracts that coat pharyngeal mucosa with a protective film.
• FluControl MAX OTC combination cold and flu medication for comprehensive symptom relief including pain, fever, nasal congestion, and discharge.
• FluControl HOT OTC powder for oral solution containing maximum-dose paracetamol (1000mg), phenylephrine (10mg), and chlorphenamine (4mg) for comprehensive flu symptom treatment.
• Diohespan max OTC venotonic medication containing diosmin and hesperidin to strengthen vein walls, reduce edema, and improve microcirculation for chronic venous insufficiency.
• Rostil OTC venous insufficiency treatment containing 250mg calcium dobesilate monohydrate per tablet, fortifying vein walls and improving microcirculation.
• Rostil max Enhanced OTC formulation for chronic venous insufficiency (CVI), reducing vascular permeability and fortifying blood vessels to prevent effusions.
• Envil kaszel OTC cough syrup containing ambroxol hydrochloride to loosen and expectorate airway secretions during respiratory tract infections.
• Envil gardło OTC throat spray and lozenges containing cetylpyridinium chloride, lidocaine, and zinc gluconate providing antiseptic and local anesthetic action.
• Envil katar OTC nasal spray containing mepyramine maleate and phenylephrine for sinusitis, rhinitis, and allergic rhinitis relief with antibacterial properties.
• Flegafortan OTC cough syrup with bromohexine hydrochloride (0.8–1.6mg/mL) to thin mucus, clear bronchial passages, and facilitate expectoration in chronic airway diseases.
• Duozinal OTC anti-allergic syrup combining 2.5mg cetirizine dihydrochloride with 58mg calcium ions per 5mL for seasonal and chronic allergic rhinitis treatment.
• Ibuprofen Aflofarm OTC ibuprofen tablets in 200mg and 400mg strengths for pain relief (toothache, headache, dysmenorrhea) and fever reduction.
• Kidofen max OTC pediatric analgesic, antipyretic, and anti-inflammatory suspension with the highest ibuprofen concentration (250mg/5mL) for children from 3 months of age.
• Polibiotic OTC topical ointment containing neomycin, polymyxin B, and bacitracin for minor wounds, scratches, burns, and bites.
• Calominal duo Medical device weight management powder containing glucomannan and chitosan to bind fats and sugars, reduce calorie absorption, and increase satiety.
• Desnoran Medical device nasal spray that moisturizes and softens throat mucosa to reduce vibrations and eliminate snoring by addressing the root cause of snoring.
• Dezaftan med OTC oral antiseptic spray with cetylpyridinium chloride, lidocaine, and zinc gluconate for mouth inflammation, gingivitis, and aphthae treatment.
• Sinumedin OTC nasal spray containing mepyramine maleate and phenylephrine for sinusitis, rhinitis, and allergic rhinitis relief.
• Naproxen Aflofarm OTC NSAID tablet containing naproxen for anti-inflammatory and analgesic effects in pain and inflammatory conditions.
• STEPER PRO OTC antifungal foot cream and spray containing 10mg bifonazole per gram for topical treatment of fungal skin infections.
• Carbo Activ Aflofarm OTC activated carbon capsules (200mg per capsule) for treatment of food poisoning, diarrhea, flatulence, and poisoning.
• Melabiorytm OTC melatonin supplement (5mg per tablet) for circadian rhythm regulation, jet lag, and shift work sleep disorders.
• Solvetusan OTC cough treatment tablet containing levodropropizine for dry non-productive cough in adults and children over 30kg.
• Nifuroksazyd Aflofarm OTC antidiarrheal film-coated tablets containing 100mg nifuroxazide for acute and chronic bacterial gastrointestinal infections.
• Stymen OTC testosterone deficiency supplement containing 10mg prasterone (DHEA) for erectile dysfunction and reduced sexual activity in men.
• Esseliv Forte OTC hepatoprotective supplement containing 300mg essential soybean phospholipids for liver diseases and liver function support.
• Bravera Control First OTC topical spray for premature ejaculation containing lidocaine (96mg/g) to reduce sensitivity and delay ejaculation.
• Regenerum Prebiotic Shampoo Prebiotic shampoo supporting scalp microbiome and hair health, awarded at Superprodukt 2025 by Świat Kobiety magazine.
• BodyMagnesium Magnesium gel and spray cosmetics product awarded at Superprodukt 2025 plebiscite by Świat Kobiety magazine.

Quantifiable outcome

• Leader in Polish OTC pharmaceutical market since 2012
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Polpharma: Poland's largest pharmaceutical manufacturer and one of the leading generics producers in Central Europe. Directly comparable to Aflofarm as a domestic Polish pharma player spanning OTC, prescription, and consumer health with broad export reach.
• USP Zdrowie: Polish OTC and consumer health pharmaceutical company with a portfolio of household brands. Comparable to Aflofarm as a domestically anchored OTC manufacturer competing in the same Polish pharmacy channel.
• Hasco-Lek: Polish pharmaceutical manufacturer specializing in OTC drugs, dietary supplements, and medical devices. Comparable to Aflofarm across product mix, channel (Polish pharmacies), and therapeutic categories.

Regional players

• Zentiva: European generics and OTC manufacturer headquartered in Prague with strong Central European presence. Comparable to Aflofarm in scale, generics/OTC focus, and geographic footprint in CEE markets where Aflofarm exports.
• KRKA: Slovenian-based generics and OTC pharmaceutical manufacturer with significant Central and Eastern European market share. Comparable to Aflofarm in product mix and CEE-centric distribution model.

Broad incumbents

• Stada Arzneimittel: Major European generics and consumer healthcare company. Comparable to Aflofarm in OTC/generics portfolio and pan-European distribution, but operates at significantly larger scale as an incumbent.
• Teva Pharmaceutical Industries: Global generics leader with significant OTC footprint. Comparable to Aflofarm in generic FDF manufacturing and broad product portfolio, though operating at vastly larger scale and global reach.
• Perrigo Company: Global OTC consumer healthcare and generics company. Comparable to Aflofarm in store-brand OTC and consumer health products, though substantially larger and more geographically diversified.
• Bayer Consumer Health: Bayer's consumer health division covers OTC and dietary supplements across multiple therapeutic categories globally. Comparable to Aflofarm in OTC self-care categories but competes against it in export markets with vastly greater scale.

Emerging players

• Glenmark Pharmaceuticals: India-headquartered generics and specialty pharma company with growing European OTC and consumer health presence. Comparable to Aflofarm as a growing international player in generic/OTC formulations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/postroniezdrowia
• LinkedInpl.linkedin.com/company/aflofarm-farmacja-polska-sp-z-o-o

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aflofarm